hSIRPA/hCD47(BALB/c)

Nomenclature

BALB/cAnSmoc-Sirpatm4(hSIRPA)SmocCd47tm1(hCD47)Smoc

Cat. NO.

NM-HU-210020

Strain State

Repository Live

Export PDF

Model Description

hCD47 (NM-HU-00050) and hSRPA(2)(NM-HU-18015) were bred with BALB/c mice respectively to generate hSIRPA/hCD47(BALB/c) mice.
Research Application：tumor research；inmmue therapy；drug screening

Validation Data

image.png

Fig.1 Detection of hCD47 expression on live cells in WT BALB/c and HO/HO hSIRPA/hCD47(BALB/c) mice.

image.png

Fig.2 Detection of hSIRPA expression on CD11b+ myeloid cells in Bone marrow in WT BALB/c and HO/HO hSIRPA/hCD47(BALB/c) mice.

image.png

Fig.3 Detection of hSIRPA expression on CD11b+ myeloid cells in Blood in WT BALB/c and HO/HO hSIRPA/hCD47(BALB/c) mice.

You may also like

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

Learn more
Workshop：Progress and Advances in Preclinical immuno-Oncology Research

SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.

Learn more